
‘Bloodshot’ Still Absent From Valiant Beyond December 2025 Solicits
MIA for two months in a row?
Valiant Comics has been through a number of iterations. First founded in 1989, it was part of the ’90s boom with hit characters like X-O Manowar, Harbinger, and Magnus, Robot Fighter. The publisher lay dormant after that for decades, until it was revamped in the mid-2010s. The characters were brought back, given a new sheen, and led to a new superhero universe.
However, through various other corporate restructurings, Valiant is once again (as of this writing) in a time of flux. After Vin Diesel’s Bloodshot failed to start a new cinematic universe, the publisher is once again focusing on their core: comics.
On Comic Book Club’s page, you can read reviews of Valiant comics. As well as listen to podcasts featuring writers, artists, editors, and more.
MIA for two months in a row?
The book has been mired in controversy, thanks to language used in the first issue.
The launch of Valiant’s new Bloodshot has been hit with a huge dust-up online, as anti-trans dogwhistles were seemingly included in the dialogue, leading to multiple apologies by publisher Alien Books and writer Mauro Mantella. Cadence Comic Art has been hit with a lawsuit by 17 artists. Marvel launches The Infernal Hulk.
I know I made a mistake, but at no point did I intend to spread a message of hate,” Mantella wrote on Instagram.
Valiant’s new Bloodshot #1 is under fire online for a panel depicting what is seen as thinly veiled transphobic dialogue.
Read the full Valiant Beyond San Diego Comic-Con 2025 Ashcan that was distributed at this year’s convention, previewing what’s coming for Valiant.
In advance of San Diego Comic-Con, Alien Books has revealed a new logo, and more projects to come including a mystery crossover.
Follow the resurgence with this digital bundle.
Lone Wolf and Cub gets the deluxe treatment. Who will die in Ultimate Spider-Man? Valiant Beyond will get an ashcan preview at San Diego Comic-Con.
Get an exclusive look at the new Valiant Beyond title.